JESSICA SABATES: Open Payments
NPI 1487285714 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 11 payments from 8 companies in 2025. Trend: 2023 $105 · 2024 $998 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Amgen Inc. | 2 | $33 |
| HEARTFLOW, INC. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| PFIZER INC. | 1 | $21 |
| BridgeBio Pharma, Inc. | 1 | $19 |
Products named: JARDIANCE, VERQUVO, REPATHA, FFRct, CAMZYOS, FARXIGA, VYNDAQEL, Attruby.
Industry payments across FL — which companies pay providers there.
